| MX4A Stock | | | EUR 228.75 0.05 0.02% |
Managing Director
Ms. Julie Holzrichter was served as Senior Managing Director, Chief Operating of the Company. Ms. Holzrichter has served as our Senior Managing Director, Chief Operating Officer since September 2014. She previously served as our Senior Managing Director, Global Operations from 2007. Ms. Holzrichter rejoined us in 2006 as our Managing Director, CME Globex Services and Technology Integration. Ms. Holzrichter previously held positions of increasing responsibility in our organization from 1986 to 2003 in trading operations. since 2014.
| Age | 54 |
| Tenure | 10 years |
| Phone | 312 930 1000 |
| Web | https://www.cmegroup.com |
CME Management Efficiency
The company has return on total asset
(ROA) of
0.0101 % which means that it generated a profit of $0.0101 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0992 %, meaning that it generated $0.0992 on every $100 dollars invested by stockholders. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities.
CME Group has accumulated 3.42
B in total debt with debt to equity ratio
(D/E) of 15.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CME Group has a current ratio of 1.03, suggesting that it
may not be capable to disburse its financial obligations in time and when they become due. Debt can assist CME until it has trouble settling it off, either with new capital or with free cash flow. So, CME's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CME Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CME to invest in growth at high rates of return. When we think about CME's use of debt, we should always consider it together with cash and equity.
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME GROUP operates under Financial Exchanges classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4590 people. CME Group (MX4A) is traded on Frankfurt Exchange in Germany and employs 3,460 people.
Management Performance
CME Group Leadership Team
Elected by the shareholders, the CME's board of directors comprises two types of representatives: CME inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CME. The board's role is to monitor CME's management team and ensure that shareholders' interests are well served. CME's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CME's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hilda Piell, Chief Human Resource Officer, Senior Managing Director | |
| Terrence Duffy, Executive Chairman of the Board and Presidentident | |
| Anita Liskey, Sr Communications | |
| Jonathan Marcus, Sr Counsel | |
| John Peschier, Managing Relations | |
| Eileen Keeve, Managing Devel | |
| Sunil Cutinho, President - CME Clearing | |
| Jack Tobin, Chief Accounting Officer, Managing Director | |
| Julie Holzrichter, Senior Managing Director - Global Operations | |
CME Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CME a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's
future performance.
For an informed investment choice regarding CME Stock, refer to the following important reports: Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
You can also try the
Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.